$VTVT Income Statement | Understand Stock

$VTVT

$25.81 +$0.26 (1.02%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Operating expenses:
Research and development
General and administrative
Total operating expenses
Operating loss
Other (expense) income, net
Nonrelated Party
Related Party
Total other (expense) income, net
Other income – related party
Interest income
Interest expense
Loss before income taxes and noncontrolling interest
Income tax provision
Net loss before noncontrolling interest
Net loss attributable to noncontrolling interest
Net loss attributable to vTv Therapeutics Inc.
Net loss attributable to vTv Therapeutics Inc. common shareholders
Net loss per share of vTv Therapeutics Inc. Class A Common Stock, basic and diluted
Weighted average number of vTv Therapeutics Inc. Class A Common Stock, basic and diluted
Net loss per share of vTv Therapeutics Inc. Class A Common Stock, basic (usd per share)
Net loss per share of vTv Therapeutics Inc. Class A Common Stock, diluted (usd per share)
Weighted average number of vTv Therapeutics Inc. Class A Common Stock, basic (in shares)
Weighted average number of vTv Therapeutics Inc. Class A Common Stock, diluted (in shares)

Comments